SLIDESHOW

Houseviews: Trading tips on 4 buzzing stocks

Wed, Feb 06, 2013 at 09:05

| Source: CNBC-TV18
Share   .   Email   .   Print      

Sun Pharma

Brokerage: Credit Suisse

Rating: Overweight

Target: Rs 840

Rationale: The doxil opportunity is still under-appreciated by the market, as it's likely to remain a low competition product and now becomes part of the base business.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.